Don’t miss out - Get your tickets early!

Join this FREE, 75-minute online webinar to gain access to insights and learn about ground-breaking treatments to chronic mental health conditions.

The Relationship between Sex & Psychedelics: Connection to Self & Other with Hamilton Morris (USA) and Kelsey Ramsden (Canada)

WEBINAR SESSION

Date: Wednesday 20 October 2021
Time: 1pm – 2:15pm (incl Q&A) (AEDT)

The presentation WILL BEGIN AT 1pm.

Location: Online. A link will be emailed to you with the viewing details.

Support these events:

Whilst our webinars are free of charge, we strongly encourage you to make a donation and support our important mission of making these therapies available through our medical system. This can be done at the time of reserving your ticket. Please share these events with your networks.

More about the presenters

Hamilton Morris (USA)

American Journalist, Documentarian, and Scientific Researcher

Hamilton Morris is a chemist, filmmaker, and science journalist. He uses an interdisciplinary approach combining anthropology and chemistry in the study of psychoactive plants, fungi, chemicals, and the cultures that surrounds them in more than thirty countries. Hamilton is the director of the award winning documentary series Hamilton's Pharmacopeia in which he explores the chemistry and traditions surrounding psychoactive drugs.

Hamilton attended the University of Chicago and The New School in New York City, where he studied anthropology and science. He frequently consults with media on the subject of psychoactive drugs and conducts pharmacological research at the University of the Sciences in Philadelphia.

Kelsey Ramsden (Canada)

Co-Founder, CEO + President MINDCURE

With over fifteen years founding, scaling, and operating innovative companies across Canada and the Caribbean, Kelsey Ramsden is globally recognized for building multiple multimillion-dollar businesses. She twice earned the honor of being named Canada’s Top Female Entrepreneur and serves on the Entrepreneurship Council for the University of Western Ontario. Kelsey is a renowned thought leader and published author and holds an MBA from the Richard Ivey School of Business at the University of Western Ontario.

Accomplishments include founding construction firm Belvedere Place Development and residential project-management company Tallus Ridge Development in British Columbia – breaking barriers in traditionally male dominated fields.

MINDCURE’S mission is to identify and develop products that ease suffering, increase productivity, and enhance mental health. It was born, in part, as a response to the mental health crisis and the need to find effective treatments in areas beyond psychiatry. These include digital therapeutics, neuro-supports, and psychedelics.

Referring to MINDCURE as the Netflix of Mental Health, Ramsden cites that the company’s digital therapeutics platform iSTRYM has parallel qualities, constantly optimizing and customizing to provide predictive, personalized recommendations.

“Our tech is more deliberate than others’ and at scale, I believe we will have the largest psychedelic repository of human experience data — which means we can shorten the time it takes to heal.”

With a psychedelic Renaissance underway, Ramsden finds herself a pioneer on a frontier (again) – and with the most precious of commodities. “We have one mind,” she said. “It’s our greatest asset.”

More about Mind Medicine Australia and medicinal psychedelic-assisted therapy:

Mind Medicine Australia is Australia’s leading not-for-profit organisation working on the use of medicinal psilocybin and MDMA-assisted therapies to treat a range of mental illnesses. Mind Medicine Australia exists to help alleviate the suffering caused by our accelerating mental illness epidemic in Australia, through expanding the treatment options available to medical practitioners and their patients.

Unlike current treatments such as anti-depressants, which only manage the illness and can have nasty side effects, psilocybin and MDMA assisted therapies have been scientifically proven to be a safe and effective cure for anxiety, depression, end-of-life stress, addictions and PTSD after just a short treatment program. These medicines are also currently being researched for dementia, eating disorders, OCD and a number of other conditions. Both medicines have been granted Breakthrough Therapy Status by the FDA in the USA to fast-track their approval. This designation is only given to medicines which may prove to be vastly superior to existing treatments.

At Mind Medicine Australia we are dedicated to helping the now global movement to spread this awareness and ensure these medicines are available via the medical system. Please watch and share our 2-minute animation to find out why psychedelic-assisted psychotherapy needs to be available to those who are suffering.

Please click here to make a tax-deductible donation.

Disclaimer

Mind Medicine Australia does not encourage or facilitate illegal use of psychedelics or plant medicines. MMA focus is focused on clinical and legal use only supported by the emerging science and legislative processes. Mind Medicine Australia reserves the right to record and publish webinars on various social media platforms. You agree that you will not discuss any names, locations or specific details of illegal use of psychedelics both verbally or via any written forms of communication via Mind Medicine Australia social media platforms (for example facebook, instagram and zoom private and public chat forms during the webinar). Breaches of these guidelines may result in not being able to participate in the event. We thank you for support and cooperation on these matters.

Mind Medicine Australia is focused specifically on the clinical application of medicinal psilocybin and medicinal MDMA for certain mental illnesses.